The fact that blocking TLR4 signaling appears to ameliorate Aβ‐induced perturbations in neurotransmitter receptor, calcium signaling, and cell cycle regulator genes, suggest that inflammation may be upstream of or at least connected to these functional responses in the AD or CAA vasculome. The gene discussed is TLR4; the disease is Alzheimer disease.